1. Narongroeknawin, P, Chevaisrakul, P, Kasitanon, N, Kitumnuaypong, T, Mahakkanukrauh, A, Siripaitoon, B et al.. Drug survival and reasons for discontinuation of the first biological disease modifying antirheumatic drugs in Thai patients with rheumatoid arthritis: Analysis from the Thai Rheumatic Disease Prior Authorization registry. Int J Rheum Dis. 2016; :. doi: 10.1111/1756-185X.12937. PubMed PMID:28737837 .
  2. Louthrenoo, W, Kasitanon, N, Katchamart, W, Aiewruengsurat, D, Chevaisrakul, P, Chiowchanwisawakit, P et al.. 2016 updated Thai Rheumatism Association Recommendations for the use of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis. Int J Rheum Dis. 2017;20 (9):1166-1184. doi: 10.1111/1756-185X.13130. PubMed PMID:28730640 .
  3. Reutrakul, S, Thakkinstian, A, Anothaisintawee, T, Chontong, S, Borel, AL, Perfect, MM et al.. Sleep characteristics in type 1 diabetes and associations with glycemic control: systematic review and meta-analysis. Sleep Med. 2016;23 :26-45. doi: 10.1016/j.sleep.2016.03.019. PubMed PMID:27692274 .
  4. Katchamart, W, Narongroeknawin, P, Chevaisrakul, P, Dechanuwong, P, Mahakkanukrauh, A, Kasitanon, N et al.. Evidence-based recommendations for the diagnosis and management of rheumatoid arthritis for non-rheumatologists: Integrating systematic literature research and expert opinion of the Thai Rheumatism Association. Int J Rheum Dis. 2017;20 (9):1142-1165. doi: 10.1111/1756-185X.12905. PubMed PMID:27452207 .
  5. Lau, CS, Chia, F, Harrison, A, Hsieh, TY, Jain, R, Jung, SM et al.. APLAR rheumatoid arthritis treatment recommendations. Int J Rheum Dis. 2015;18 (7):685-713. doi: 10.1111/1756-185X.12754. PubMed PMID:26334449 .
  6. Pitipakorn, U, Suwannalai, P, Trachoo, O, Rattanasiri, S, Chitphuk, S, Ngamjanyaporn, P et al.. Angiotensin-converting enzyme gene polymorphism in Thai patients with systemic lupus erythematosus. Int J Rheum Dis. 2016;19 (7):693-9. doi: 10.1111/1756-185X.12609. PubMed PMID:26200015 .
  7. Wacharapornin, P, Suwannalai, P. Predictors for low disease activity and remission in rheumatoid arthritis patients treated with biological DMARDs. J Med Assoc Thai. 2014;97 (11):1157-63. . PubMed PMID:25675680 .
  8. Navarra, SV, Tang, B, Lu, L, Lin, HY, Mok, CC, Asavatanabodee, P et al.. Risk of tuberculosis with anti-tumor necrosis factor-α therapy: substantially higher number of patients at risk in Asia. Int J Rheum Dis. 2014;17 (3):291-8. doi: 10.1111/1756-185X.12188. PubMed PMID:24131578 PubMed Central PMC4034594.
  9. Suwannalai, P, Britsemmer, K, Knevel, R, Scherer, HU, Levarht, EW, van der Helm-van Mil, AH et al.. Low-avidity anticitrullinated protein antibodies (ACPA) are associated with a higher rate of joint destruction in rheumatoid arthritis. Ann. Rheum. Dis. 2014;73 (1):270-6. doi: 10.1136/annrheumdis-2012-202615. PubMed PMID:23463689 .
  10. Suwannalai, P, van de Stadt, LA, Radner, H, Steiner, G, El-Gabalawy, HS, Zijde, CM et al.. Avidity maturation of anti-citrullinated protein antibodies in rheumatoid arthritis. Arthritis Rheum. 2012;64 (5):1323-8. doi: 10.1002/art.33489. PubMed PMID:22130974 .
  11. Suwannalai, P, Willemze, A, van Toorn, L, Stoeken-Rijsbergen, G, Levarht, N, Drijfhout, JW et al.. The fine specificity of IgM anti-citrullinated protein antibodies (ACPA) is different from that of IgG ACPA. Arthritis Res. Ther. 2011;13 (6):R195. doi: 10.1186/ar3524. PubMed PMID:22129077 PubMed Central PMC3334645.
  12. Shi, J, Knevel, R, Suwannalai, P, van der Linden, MP, Janssen, GM, van Veelen, PA et al.. Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage. Proc. Natl. Acad. Sci. U.S.A. 2011;108 (42):17372-7. doi: 10.1073/pnas.1114465108. PubMed PMID:21987802 PubMed Central PMC3198314.
  13. Vananuvat, P, Suwannalai, P, Sungkanuparph, S, Limsuwan, T, Ngamjanyaporn, P, Janwityanujit, S et al.. Primary prophylaxis for Pneumocystis jirovecii pneumonia in patients with connective tissue diseases. Semin. Arthritis Rheum. 2011;41 (3):497-502. doi: 10.1016/j.semarthrit.2011.05.004. PubMed PMID:21959291 .
  14. Suwannalai, P, Trouw, LA, Toes, RE, Huizinga, TW. Anti-citrullinated protein antibodies (ACPA) in early rheumatoid arthritis. Mod Rheumatol. 2012;22 (1):15-20. doi: 10.1007/s10165-011-0486-8. PubMed PMID:21732051 .
  15. Suwannalai, P, Scherer, HU, van der Woude, D, Ioan-Facsinay, A, Jol-van der Zijde, CM, van Tol, MJ et al.. Anti-citrullinated protein antibodies have a low avidity compared with antibodies against recall antigens. Ann. Rheum. Dis. 2011;70 (2):373-9. doi: 10.1136/ard.2010.135509. PubMed PMID:21068094 .
  16. Suwannalai, P, Auethavekiat, P, Udomsubpayakul, U, Janvitayanujit, S. The infectious profiles of anti-tumor necrosis factor agents in a Thai population: a retrospective study a the university-based hospital. Int J Rheum Dis. 2009;12 (2):118-24. doi: 10.1111/j.1756-185X.2009.01393.x. PubMed PMID:20374328 .
  17. Vanichapuntu, M, Phuekfon, P, Suwannalai, P, Verasertniyom, O, Nantiruj, K, Janwityanujit, S et al.. Are anti-citrulline autoantibodies better serum markers for rheumatoid arthritis than rheumatoid factor in Thai population?. Rheumatol. Int. 2010;30 (6):755-9. doi: 10.1007/s00296-009-1058-5. PubMed PMID:19597732 .
  18. Jaovisidha, S, Denprechawong, R, Suwannalai, P, Janwityanujit, S. Asymptomatic avascular osteonecrosis of the hip in new patients diagnosed as systemic lupus erythematosus in Ramathibodi Hospital. J Med Assoc Thai. 2007;90 (7):1382-90. . PubMed PMID:17710981 .
Search PubMed